SMAD2 and esophageal squamous cell carcinoma: Moreover, RUNX3 inhibited the invasion and migration of ESCC cells by reversing the EMT through TGFβ/Smad signaling, consistent with RUNX3 overexpression markedly inhibiting the phosphorylation of SMAD2/3 [25].